Standard reduction approaches may be appropriate for individuals taking antidepressants that have no past history of distressing withdrawal, and no particular fear of withdrawing and/or stopping antidepressants over four to six weeks.

Review and reduce dose every one to four weeks, or as guided by the individual’s needs and/or preferences. However, reducing by one step every four weeks may be more practical for individuals due to their carer, family and work commitments, as well as for collecting prescriptions and enabling appropriate face-to-face or telephone review follow-up.

Selective serotonin re-uptake inhibitors (SSRIs)

Selective serotonin re-uptake inhibitors (SSRIs):143 Due to the long half-life, the following can be stopped at standard daily doses: citalopram 20mg, escitalopram 10mg, fluoxetine 20mg and sertraline 50mg per day. However, individuals may prefer or require a slower reduction with lower doses.

Example SSRI dose reduction steps

SSRIs Step 1  Step 2  Step 3  Step 4  Step 5  Step 6
Citalopram 40mg 30mg 20mg 10mg Stop  - 
Escitalopram 20mg 15mg 10mg 5mg Stop  - 
Fluoxetine 40mg 30mg* 20mg 10mg** Stop  - 
Fluvoxamine 300mg 200mg 100mg 50mg Stop  - 
Sertraline 200mg 150mg 100mg 50mg 25mg Stop
Paroxetine 40mg 30mg 20mg 10mg 5mg†† Stop
  • Steps: the rate of withdrawal will vary with individual needs e.g. weekly to four weekly reductions for some
  • All doses are single daily doses
  • * Alternate day dosing 40mg/20mg
  • ** Alternate day dosing with 20mg capsule, or consider using fluoxetine liquid
  • † Some individuals may require to be switched to an alternative SSRI if experiencing significant withdrawals, see below.
  • †† Half a 10mg tablet

 

Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

Most individuals will be able to slowly withdraw and discontinue duloxetine and venlafaxine without any adverse effects. Where individuals experience discontinuation/withdrawal effects after stopping, it may be appropriate to restart the antidepressant at the previous dose and frequency for seven days then switch to a long-acting SSRI if interactions and contra-indications allow.

Example SNRI dose reduction steps

SNRI Step 1  Step 2  Step 3  Step 4  Step 5  Step 6
Duloxetinea 120mg 90mg 60mg 30mg Stop  - 
Venlafaxine MRb 300mg 225mg 150mg 75mg 37.5mg  Stop
Venlafaxinec 150mg twice daily 150mg morning, 75mg night 75mg twice daily 37.5mg twice daily Stopd  - 

Steps: the rate of withdrawal will vary with individual needs e.g. weekly to four weekly reductions for some, or longer and slower reductions for others.

Note: Venlafaxine 300mg daily used as example, as individuals on higher doses are usually under the care of community mental health teams who should be involved in decisions to reduce or withdraw.

  1. BNF only has 60mg dose listed for treatment of major depressive order. Duloxetine SmPC (data sheet) quotes up to 120mg daily. However, there is no clinical evidence suggesting that individuals not responding to the initial recommended dose may benefit from dose up-titrations.144
  2. If receiving modified-release (MR) preparations as split dose e.g. twice daily, please consider that MR preparations are intended as once daily preparations.
  3. Some individuals may have a preference for reducing the night-time or morning dose first.
  4. If needed venlafaxine 37.5mg MR daily could be used for another step before stopping.

 

Tricyclic antidepressants (TCAs)

Frail and/or older adults may require and need slower reduction to minimise the risk of cholinergic rebound (nausea, vomiting, headache, restlessness). Therefore, slow reduction over longer than six weeks, or months, may be needed for some individuals depending on their preference and/or needs.

Example TCA dose reduction steps

TCA Step 1  Step 2  Step 3  Step 4  Step 5  Step 6 Step 7 Step 8
Amitryptylinea 150mg 100mg 50mg Stop  -   -   -   - 
Amitryptylinea,b 150mg 125mg 100mg 75mg 50mg  25mg 10mgc Stop
Lofepramined 210mg 140mg 70mg 35mge Stop  -   -   - 
  1. The same reduction schedule could be advised for: Clomipramine, Dosulepin (dothiepin), Doxepin, Imipramine, Nortriptyline, Trimipramine
  2. Older adults and some individuals may require reductions using smaller dose increments to minimise the risk of adverse withdrawal effects/harms.
  3. Dosulepin and doxepin not available as 10mg dose, therefore, consider if necessary, using 25mg capsules on alternate days, then stop.
  4. If dose is split morning and night, consider reducing and stopping morning dose first, and then continuing reduction with nighttime dose.
  5. Tablets are less suitable for halving as they have a film coating. If necessary, a 35mg dose can be given using lofepramine 70mg/5ml oral suspension.

 

Other antidepressants and monoamine oxidase inhibitors (MAOIs)

Example dose reduction steps for other antidepressants and MAOIs

Other antidepressants/MAOIs  Step 1  Step 2  Step 3  Step 4  Step 5 Step 6 Step 7
Agomelatine 50mg 25mg Stop  -   -   -   - 
Mirtazapine 45mg 30mg 15mga Stop  -  -   - 
Trazodone 300mgb 250mg 200mg 150mg 100mg  50mg Stop
Vortioxetine 20mg 10mg Stop  -   -   -   - 
Isocarboxazidc Morning 60mg 50mg 40mg 30mg 20mg 10mg Stop
Moclobemided
Morning 300mg 300mg 150mg 150mg Stop  -   - 
Night 300mg 150mg 150mg Stop  -   -   - 
Phenelzinec
Morning 30mg 30mg 30mg 15mg 15mg 15mg Stop
Afternoon 30mg 15mg 15mg 15mg Stop Stop  - 
Night 30mg 30mg 15mg 15mg 15mg Stop  - 
Tranylcyprominec Morning 30mg 20mg 10mg Stop  -   -   - 

Steps: the rate of withdrawal will vary with individual needs e.g. weekly to four weekly reductions for some.

  1. Some individuals may find the 15mg dose more sedating than higher doses due to greater antihistamine effects at lower doses.
  2. For higher doses consider reducing at each step by 50mg. However, clinical need and/or individual preferences may require larger reduction steps e.g. 100mg.
  3. Isocarboxazid, phenelzine and tranylcypromine inhibit monoamine oxidase A and B for up to two weeks after stopping. Consider risk of interactions for two weeks after stopping.
  4. Moclobemide is a reversible inhibitor of monoamine oxidase A.